Exercise Program for Parkinson's Disease
(LifePD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a home-based exercise program for people with Parkinson's disease. It compares the effects of a combined aerobic and resistance exercise routine to a stretching and flexibility routine. The goal is to determine if the exercise program, called GET Up PD, can improve physical activity, cognitive function, symptoms, and quality of life. The trial seeks participants who have Parkinson's, are not very active, and can walk without assistance. Participants will receive exercise equipment, coaching, and support through online chats. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance daily living for those with Parkinson's.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to consult with the trial coordinators or your doctor for guidance.
What prior data suggests that this exercise program is safe for individuals with Parkinson's disease?
This trial focuses on an exercise program called GET Up PD, designed for people with Parkinson's disease. Research has shown that exercise programs like GET Up PD are generally safe. Exercise, a non-drug treatment, is well-tolerated by many, including those with Parkinson's.
The program includes aerobic exercises (such as walking or cycling) and resistance training (like weight lifting). These exercises are often recommended for overall health and have been shown to improve symptoms in people with Parkinson's without causing significant side effects. No serious problems have been reported with these types of exercise programs for Parkinson's. However, as with any physical activity, a small risk of injury exists, but this risk remains low when exercises are performed correctly and with guidance.
Based on evidence from similar exercise treatments, GET Up PD should be safe for participants. It is important to consult a healthcare provider to ensure any new exercise program is appropriate.12345Why are researchers excited about this trial?
Researchers are excited about the GET Up PD program because it offers a fresh approach to managing Parkinson's disease through a remotely-coached, home-based exercise regimen. Unlike traditional treatments that often focus on medication, GET Up PD emphasizes aerobic fitness and muscle strength, using telerehabilitation to guide patients in their own homes. This method not only enhances accessibility for people living with Parkinson's but also encourages consistent physical activity, which is crucial for managing symptoms. Additionally, the use of telerehabilitation makes it easier for patients to receive personalized coaching without having to travel, which is a significant advantage over conventional exercise programs that require in-person visits.
What evidence suggests that this exercise program is effective for Parkinson's disease?
This trial will compare two exercise programs for people with Parkinson's disease. Participants in one arm will engage in the GET Up PD program, a remotely-coached, home-based program focusing on aerobic fitness and muscle strength. Research has shown that exercise programs like GET Up PD can help people with Parkinson's disease by boosting physical activity and improving thinking skills. Such exercise routines are linked to a better quality of life and fewer symptoms. Evidence suggests these benefits result from increased fitness and muscle strength, which are important for managing Parkinson's symptoms. Overall, regular exercise might offer a way to help manage the condition without medication.678910
Who Is on the Research Team?
Robert Motl, Ph.D
Principal Investigator
University of Illinois at Chicago
Are You a Good Fit for This Trial?
This trial is for physically inactive individuals with Parkinson's Disease who are interested in improving their physical activity, cognitive function, symptoms, and quality of life. Participants will engage in a 16-week program from home using Zoom and must be willing to follow the exercise or stretching routines provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 16-week remotely-delivered, social-cognitive theory-based behavioral intervention focusing on combined exercise (aerobic and resistance) training or active control (flexibility and stretching) condition.
Follow-up
Participants are monitored for changes in cognitive function, symptoms, and quality of life after the intervention.
What Are the Treatments Tested in This Trial?
Interventions
- GET Up PD
Trial Overview
The study tests a social-cognitive theory-based behavioral intervention that includes aerobic and resistance exercises (GET Up PD) against an active control group doing flexibility and stretching. It aims to see if the exercise training can improve physical activity levels, cognitive functions, symptoms, and quality of life over 16 weeks.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Remotely-coached/guided, home-based program delivered using telerehabilitation focusing on aerobic fitness and muscle strength as a mode of training
Remotely-coached/guided, home-based program delivered using telerehabilitation focusing on stretching and range of motion as the mode of training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
Published Research Related to This Trial
Citations
Outcome Measures for Disease-Modifying Trials in ...
This approach aimed to guide the maximal number of outcome measures/visit to be included in a disease-modifying PD trial. All outcome ...
Key Findings
Researchers used Parkinson's Outcomes Project data to better define demographic and treatment patterns in the young-onset Parkinson disease (YOPD) population.
3.
parkinsonsnewstoday.com
parkinsonsnewstoday.com/news/lasting-relief-parkinsons-motor-symptoms-found-dbs-us-study/Lasting relief of Parkinson's motor symptoms found with DBS
This dropped to 21.1 after one year, showing a 51% improvement. At five years, the score was 27.6, still reflecting a 36% improvement compared ...
A Consensus Set of Outcomes for Parkinson's Disease ...
We identified four additional domains as important for patients with PD: ability to work, hospital admissions, overall PD-related health status, and falls.
Outcome Assessment in Parkinson Disease Prevention Trials
Using claims data, they identified 3,862 individuals who developed PD over a median of 3.5 years of follow-up. Participants with slow TUG ...
Safety of AADC Gene Therapy for Moderately Advanced ...
This study provides Class IV evidence that, in patients with moderately advanced PD and motor fluctuations, putaminal infusion of VY-AADC01 is well tolerated ...
PD-DETECTOR: A sustainable and computationally ...
This paper introduces a mobile cloud-based predictive model for assisting Parkinson's disease (PD) patients.
The efficacy and safety of MARS-PD: Meridian activation ...
The primary endpoint is the change in MDS-UPDRS Part III score from baseline to the conclusion of the 8-week intervention. Secondary outcomes encompass various ...
Sensing data and methodology from the Adaptive DBS ...
Here we summarize sensing data and aDBS programming steps associated with the ongoing Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease ( ...
Study Details | NCT05635409 | A Trial to Determine the ...
In this trial, the investigators will transplant a new stem cell therapy, called the STEM-PD product, into the area of the brain affected in people with PD.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.